Abstract
This strategic analysis identifies the current trends in scientific business
intelligence (Sci-BI) in pharmaceutical and biotechnology markets. Major
global healthcare trends are analyzed and the impacts on Sci-BI are
delineated. A close look at drivers and restraints in the Sci-BI space
revealed interesting growth stimulators while also identifying critical road
blocks in the growth of the Sci-BI market. A step by step analysis of the R&D
cost distribution in pharma/biotech was carried out together with a
competitive landscape analysis of the different players in this niche market
segment.
| 
View Cart
